Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q1 2018 · 10-Q
Revenue$344.62K$344.62K+64.1% vs Q1 2017 Net Income$20.01K$20.01KN/M vs Q1 2017 EPS Diluted$0.00$0.00N/M vs Q1 2017 Gross Profit$174,448+66.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flow$24,642N/M Free Cash Flowderived$11,890N/M Margins · derivedGross margin50.6%+0.9 pt vs Q1 2017
Operating margin4.6%+33.8 pt vs Q1 2017
Net margin5.8%+35.3 pt vs Q1 2017
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end